Oruka Therapeutics (ORKA) Cash & Equivalents Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 36.53% |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | 3.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.59% |
| Dec 31, 2025 | 124.05% |
| Sep 30, 2025 | 26.52% |
| Jun 30, 2025 | 12.09% |
| Mar 31, 2025 | 95.90% |
| Dec 31, 2024 | 4.89% |
| Sep 30, 2024 | 90.53% |
| Jun 30, 2024 | -19.24% |
| Mar 31, 2024 | -18.75% |
| Dec 31, 2023 | -8.63% |
| Sep 30, 2023 | -9.01% |
| Jun 30, 2023 | 53.79% |
| Mar 31, 2023 | 82.92% |
| Dec 31, 2022 | 71.85% |
| Sep 30, 2022 | 65.77% |
| Jun 30, 2022 | 67.02% |
| Mar 31, 2022 | 82.99% |
| Dec 31, 2021 | 100.62% |
| Sep 30, 2021 | 93.27% |
| Jun 30, 2021 | 87.19% |
| Mar 31, 2021 | 76.87% |
| Dec 31, 2020 | 77.99% |
| Sep 30, 2020 | 84.45% |
| Jun 30, 2020 | 6.65% |
| Mar 31, 2020 | 2.65% |
| Dec 31, 2019 | 4.16% |
| Sep 30, 2019 | 6.01% |
| Jun 30, 2019 | -11.50% |
| Mar 31, 2019 | -35.41% |
| Dec 31, 2018 | -44.57% |
| Sep 30, 2018 | -42.04% |
| Jun 30, 2018 | -39.76% |
| Mar 31, 2018 | -0.24% |
| Dec 31, 2017 | -17.24% |
| Sep 30, 2017 | -22.14% |
| Jun 30, 2017 | -22.27% |
| Mar 31, 2017 | -33.73% |
| Dec 31, 2016 | -23.84% |
| Sep 30, 2016 | -24.26% |
| Jun 30, 2016 | -10.97% |
| Mar 31, 2016 | 103.29% |
| Dec 31, 2015 | 136.86% |
| Sep 30, 2015 | 137.90% |
| Jun 30, 2015 | 140.18% |
| Mar 31, 2015 | 42.32% |
| Dec 31, 2014 | 37.22% |
| Sep 30, 2014 | 44.24% |
| Jun 30, 2014 | 37.44% |
| Mar 31, 2014 | 60.95% |
| Dec 31, 2013 | 33.61% |
| Sep 30, 2013 | 33.08% |
| Jun 30, 2013 | 27.13% |